Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 3/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | DUT | P33316 | 5/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3752207 | 0.76 | CRBN (0.40) | CRBNPKMDDB1ALDH1A1LMNA | |
| SCHEMBL8933242 | 0.74 | CRBN (0.41) | CRBNPKMDDB1ALDH1A1LMNA | |
| SCHEMBL3541014 | 0.74 | CRBN (0.54) | CRBNPKMDDB1ALDH1A1LMNA | |
| SCHEMBL9763767 | 0.73 | CRBN (0.42) | CRBNPKMDUT | |
| SCHEMBL25430771 | 0.72 | GPR84 (0.44) | CRBN | |
| SCHEMBL29138705 | 0.71 | MAPK1 (0.41) | ALDH1A1LMNA | |
| SCHEMBL5604080 | 0.71 | PKM (0.40) | CRBNPKMDDB1ALDH1A1LMNA | |
| SCHEMBL2181554 | 0.70 | CRBN (0.54) | CRBNPKMDDB1ALDH1A1LMNA | |
| SCHEMBL22144561 | 0.69 | PKM (0.47) | CRBNPKMDDB1ALDH1A1LMNA | |
| SCHEMBL7632468 | 0.68 | CRBN (0.47) | CRBNPKMDDB1ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025038963-A1 | OLIGONUCLEOTIDES CONTAINING MULTIPLE LIGANDS AND/OR LIPIDS | ADARX PHARMACEUTICALS, INC. (US) | 2025-02-20 | — | — | WO | claimed |
| WO-2025111430-A1 | CHEMICAL MODIFICATIONS IN mRNA POLY(A) TAIL | PRIME MEDICINE, INC. (US) | 2025-05-30 | — | — | WO | disclosed |
| WO-2025080995-A1 | PHARMACEUTICAL AGENT-INTEGRIN LIGAND CONJUGATES FOR MUSCLE DELIVERY | ADARX PHARMACEUTICALS, INC. (US) | 2025-04-17 | — | — | WO | disclosed |
| CN-115867670-A | Base-modified nucleotides as substrates for TDT-based enzyme nucleic acids | 伊鲁米纳新加坡有限公司 | 2023-03-28 | — | — | CN | disclosed |